Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-9901: Chemotherapy + RT for Advanced Nasopharyngeal Carcinoma
NCT00563927Phase 3Unknown
- Sponsor
- Hospital Authority
- Start
- Mar 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Hospital Authority. Primary endpoint: Failure-Free Survival Rate at 5 years. Status: unknown.
02
Drugs
cisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00563927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563927.